Variant report

Variant	nsv886836
Chromosome Location	chr6:162234333-162310091
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
2	chr6:162307888..162309501-chr6:162310852..162312650,2	K562	blood:
3	chr6:162258117..162258784-chr6:162338530..162339165,2	MCF-7	breast:
4	chr6:162258059..162258779-chr6:162552660..162553528,2	MCF-7	breast:
5	chr6:162274815..162277621-chr6:162282085..162283805,2	K562	blood:
6	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
7	chr6:162291697..162293198-chr6:162305600..162307370,2	K562	blood:
8	chr6:162232298..162233805-chr6:162237071..162239613,2	K562	blood:

No data

Extended variants
information (count: 3345 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:3345 , 50 per page) page: 1 2 3 4 5 6 7 ... 67

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7739802	chr6:162234333-162234334	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs540326162	chr6:162234359-162234360	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs117040941	chr6:162234363-162234364	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs576955449	chr6:162234390-162234391	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs572295594	chr6:162234396-162234397	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs540621050	chr6:162234400-162234401	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs150338701	chr6:162234401-162234402	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs138088142	chr6:162234419-162234420	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs552719729	chr6:162234458-162234459	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs562903152	chr6:162234513-162234514	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs531939525	chr6:162234530-162234531	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs548547927	chr6:162234552-162234553	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs568728747	chr6:162234573-162234574	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs543220578	chr6:162234614-162234615	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
15	rs534252730	chr6:162234626-162234627	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
16	rs546964334	chr6:162234635-162234636	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
17	rs570132019	chr6:162234647-162234648	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
18	rs539109051	chr6:162234651-162234652	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
19	rs555850192	chr6:162234667-162234668	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
20	rs576108247	chr6:162234684-162234685	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
21	rs535635034	chr6:162234725-162234726	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
22	rs544111550	chr6:162234763-162234764	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
23	rs35229245	chr6:162234779-162234780	ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
24	rs555312694	chr6:162234801-162234802	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs143777263	chr6:162234878-162234879	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs147216169	chr6:162234900-162234901	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs138687097	chr6:162234933-162234934	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs577320437	chr6:162234968-162234969	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs560034441	chr6:162235053-162235054	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs369978242	chr6:162235055-162235056	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs182328341	chr6:162235084-162235085	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs1122327	chr6:162235108-162235109	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs117906693	chr6:162235117-162235118	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs548570864	chr6:162235121-162235122	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs542396104	chr6:162235199-162235200	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs142685978	chr6:162235245-162235246	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs144507076	chr6:162235256-162235257	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs148420361	chr6:162235284-162235285	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs142928796	chr6:162235320-162235321	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs150655297	chr6:162235321-162235322	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs559193001	chr6:162235359-162235360	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs549557602	chr6:162235367-162235368	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs569722575	chr6:162235397-162235398	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs140129033	chr6:162235398-162235399	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs143945785	chr6:162235444-162235445	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs112914440	chr6:162235471-162235472	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs186664581	chr6:162235500-162235501	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs140543201	chr6:162235502-162235503	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs7450539	chr6:162235543-162235544	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs7453971	chr6:162235544-162235545	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Bipolar disorder	19114987	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:320 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162220600-162234600	Weak transcription	Ovary	ovary
2	chr6:162234600-162234800	ZNF genes & repeats	Ovary	ovary
3	chr6:162234800-162236200	Weak transcription	Ovary	ovary
4	chr6:162236400-162237200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr6:162236400-162237200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr6:162236400-162237400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr6:162236600-162237000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr6:162236600-162237000	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr6:162236600-162237200	Enhancers	NHEK	skin
10	chr6:162236600-162237400	Enhancers	iPS-18 Cell Line	embryonic stem cell
11	chr6:162236600-162238200	Enhancers	Fetal Brain Male	brain
12	chr6:162237200-162238400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr6:162238200-162243200	Weak transcription	Fetal Brain Male	brain
14	chr6:162238400-162238600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr6:162243200-162243600	Enhancers	Fetal Brain Male	brain
16	chr6:162243600-162244400	Weak transcription	Fetal Brain Male	brain
17	chr6:162244400-162245200	Enhancers	Fetal Brain Male	brain
18	chr6:162245000-162245200	Enhancers	Primary hematopoietic stem cells short term culture	blood
19	chr6:162245200-162246600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
20	chr6:162245200-162247600	Weak transcription	Fetal Brain Male	brain
21	chr6:162246600-162246800	Enhancers	Primary hematopoietic stem cells short term culture	blood
22	chr6:162246800-162247600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
23	chr6:162247600-162248400	Enhancers	Fetal Brain Male	brain
24	chr6:162247600-162250200	Enhancers	Primary hematopoietic stem cells short term culture	blood
25	chr6:162247800-162248000	Enhancers	Primary hematopoietic stem cells	blood
26	chr6:162247800-162248000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr6:162248000-162248400	Enhancers	Fetal Brain Female	brain
28	chr6:162248000-162249000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr6:162248200-162249200	Weak transcription	Primary hematopoietic stem cells	blood
30	chr6:162248400-162250400	Weak transcription	Fetal Brain Male	brain
31	chr6:162248400-162256800	Weak transcription	Fetal Brain Female	brain
32	chr6:162249000-162249200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr6:162249000-162255600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr6:162249200-162249600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr6:162249200-162253600	Enhancers	Primary hematopoietic stem cells	blood
36	chr6:162249400-162249600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr6:162249400-162249800	Enhancers	Fetal Muscle Trunk	muscle
38	chr6:162249400-162251200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr6:162249400-162251200	Enhancers	Brain Hippocampus Middle	brain
40	chr6:162249600-162250200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr6:162249600-162251200	Enhancers	Thymus	Thymus
42	chr6:162249600-162252000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr6:162249600-162252400	Enhancers	Fetal Thymus	thymus
44	chr6:162249800-162251200	Enhancers	Brain Substantia Nigra	brain
45	chr6:162250000-162250200	Enhancers	H9 Cell Line	embryonic stem cell
46	chr6:162250000-162251200	Enhancers	Cortex derived primary cultured neurospheres	brain
47	chr6:162250200-162250400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
48	chr6:162250200-162250400	Enhancers	Brain Angular Gyrus	brain
49	chr6:162250200-162250400	Enhancers	Brain Anterior Caudate	brain
50	chr6:162250200-162250800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links